Eltenac

DB20457ExperimentalSmall molecule

Eltenac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Eltenac is a anti-inflammatory agent, ibufenac derivative. Eltenac has a monoisotopic molecular...

Formula / weight: C₁₂H₉Cl₂NO₂S · 302.17 g/mol (avg)

Resolves to

Compound

UNIIA153L3JA99CAS72895-88-6ChEMBLCHEMBL2104561

Structure

InChIKeyAELILMBZWCGOSB-UHFFFAOYSA-NSMILESOC(=O)CC1=CSC=C1NC1=C(Cl)C=CC=C1Cl

Targets

P23219PTGS1P35354PTGS2

What you can answer from here — as of September 19, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Eltenac, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account